Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bicycle Therapeutics plc BCYC

Healthcare Biotechnology
Bicycle Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycle molecules, for diseases that are underserved by existing therapeutics. Bicycle molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. The Company is... see more

Recent & Breaking News (NDAQ:BCYC)

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

Business Wire 3 days ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire 13 days ago

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

Business Wire October 31, 2024

Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals

Business Wire October 23, 2024

Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress

Business Wire October 16, 2024

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire October 2, 2024

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

Business Wire September 14, 2024

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire September 3, 2024

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Business Wire August 21, 2024

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

Business Wire August 6, 2024

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire August 1, 2024

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

Business Wire July 22, 2024

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Business Wire June 3, 2024

Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting

Business Wire May 23, 2024

Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing

Business Wire May 23, 2024

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

Business Wire May 2, 2024

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

Business Wire April 24, 2024

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Business Wire April 2, 2024

Bicycle Therapeutics to Present at the AACR Annual Meeting 2024

Business Wire March 5, 2024

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Business Wire February 28, 2024